Sirpiglenastat, also known as DRP-104, is a prodrug of 6-diazo-5-oxo-L-norleucine (DON), a broad-acting glutamine antagonist. It is under investigation in clinical trials for advanced solid tumors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sirpiglenastat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Hexarelin acetate
pharmaceutical raw material
Digoxin
pharmaceutical raw material
Daunorubicin
pharmaceutical raw material
Micafungin sodium
pharmaceutical raw material
The international HS code for Sirpiglenastat (CAS 2079939-05-0) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
propan-2-yl (2S)-2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-6-diazo-5-oxohexanoate
LQNMCWOJACNQQM-PMACEKPBSA-N
CC(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)C
Sourcing Sirpiglenastat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.